These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 24443555)
1. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells. Xia S; Wei J; Wang J; Sun H; Zheng W; Li Y; Sun Y; Zhao H; Zhang S; Wen T; Zhou X; Gao JX; Wang P; Wu Z; Zhao L; Yin Z J Leukoc Biol; 2014 May; 95(5):733-742. PubMed ID: 24443555 [TBL] [Abstract][Full Text] [Related]
2. Targeted knock down of CCL22 and CCL17 by siRNA during DC differentiation and maturation affects the recruitment of T subsets. Kang S; Xie J; Ma S; Liao W; Zhang J; Luo R Immunobiology; 2010; 215(2):153-62. PubMed ID: 19450895 [TBL] [Abstract][Full Text] [Related]
4. Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression. Belle L; Agle K; Zhou V; Yin-Yuan C; Komorowski R; Eastwood D; Logan B; Sun J; Ghilardi N; Cua D; Williams CB; Gaignage M; Marillier R; van Snick J; Drobyski WR Blood; 2016 Oct; 128(16):2068-2082. PubMed ID: 27488350 [TBL] [Abstract][Full Text] [Related]
5. INFα-2b inhibitory effects on CD4(+)CD25(+)FOXP3(+) regulatory T cells in the tumor microenvironment of C57BL/6 J mice with melanoma xenografts. Yu Y; Huang R; Zong X; He X; Mo W BMC Cancer; 2016 Jul; 16():397. PubMed ID: 27389040 [TBL] [Abstract][Full Text] [Related]
6. Targeting Interleukin(IL)-30/IL-27p28 signaling in cancer stem-like cells and host environment synergistically inhibits prostate cancer growth and improves survival. Sorrentino C; Yin Z; Ciummo S; Lanuti P; Lu LF; Marchisio M; Bellone M; Di Carlo E J Immunother Cancer; 2019 Jul; 7(1):201. PubMed ID: 31366386 [TBL] [Abstract][Full Text] [Related]
7. Dynamics of T-cell infiltration during the course of ovarian cancer: the gradual shift from a Th17 effector cell response to a predominant infiltration by regulatory T-cells. Fialová A; Partlová S; Sojka L; Hromádková H; Brtnický T; Fučíková J; Kocián P; Rob L; Bartůňková J; Spíšek R Int J Cancer; 2013 Mar; 132(5):1070-9. PubMed ID: 22865582 [TBL] [Abstract][Full Text] [Related]
8. CCL17 and CCL22 chemokines within tumor microenvironment are related to accumulation of Foxp3+ regulatory T cells in gastric cancer. Mizukami Y; Kono K; Kawaguchi Y; Akaike H; Kamimura K; Sugai H; Fujii H Int J Cancer; 2008 May; 122(10):2286-93. PubMed ID: 18224687 [TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-derived interleukin-1β activates protumor C-C motif chemokine ligand 22 signaling in head and neck cancer. Huang YH; Chang CY; Kuo YZ; Fang WY; Kao HY; Tsai ST; Wu LW Cancer Sci; 2019 Sep; 110(9):2783-2793. PubMed ID: 31325403 [TBL] [Abstract][Full Text] [Related]
11. CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells. Ribas A; Butterfield LH; Amarnani SN; Dissette VB; Kim D; Meng WS; Miranda GA; Wang HJ; McBride WH; Glaspy JA; Economou JS Cancer Res; 2001 Dec; 61(24):8787-93. PubMed ID: 11751400 [TBL] [Abstract][Full Text] [Related]
12. Critical role of dendritic cell-derived IL-27 in antitumor immunity through regulating the recruitment and activation of NK and NKT cells. Wei J; Xia S; Sun H; Zhang S; Wang J; Zhao H; Wu X; Chen X; Hao J; Zhou X; Zhu Z; Gao X; Gao JX; Wang P; Wu Z; Zhao L; Yin Z J Immunol; 2013 Jul; 191(1):500-8. PubMed ID: 23733881 [TBL] [Abstract][Full Text] [Related]
13. CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype. Guo Z; Jang MH; Otani K; Bai Z; Umemoto E; Matsumoto M; Nishiyama M; Yamasaki M; Ueha S; Matsushima K; Hirata T; Miyasaka M Int Immunol; 2008 Mar; 20(3):307-15. PubMed ID: 18184698 [TBL] [Abstract][Full Text] [Related]
14. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients. Wertel I; Surówka J; Polak G; Barczyński B; Bednarek W; Jakubowicz-Gil J; Bojarska-Junak A; Kotarski J Tumour Biol; 2015 Jun; 36(6):4811-7. PubMed ID: 25647263 [TBL] [Abstract][Full Text] [Related]
15. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs. Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Effect of Imiquimod Through CCL22 Produced by Tumor-associated Macrophages in B16F10 Melanomas. Furudate S; Fujimura T; Kambayashi Y; Kakizaki A; Hidaka T; Aiba S Anticancer Res; 2017 Jul; 37(7):3461-3471. PubMed ID: 28668835 [TBL] [Abstract][Full Text] [Related]
17. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen. Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899 [TBL] [Abstract][Full Text] [Related]
18. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Guo J; Wang B; Zhang M; Chen T; Yu Y; Regulier E; Homann HE; Qin Z; Ju DW; Cao X Gene Ther; 2002 Jun; 9(12):793-803. PubMed ID: 12040461 [TBL] [Abstract][Full Text] [Related]
19. IL-35 inhibits HBV antigen-specific IFN-γ-producing CTLs in vitro. Li X; Tian L; Dong Y; Zhu Q; Wang Y; Han W; Liu X; Ni Q; Chen Y; Li L Clin Sci (Lond); 2015 Sep; 129(5):395-404. PubMed ID: 25869609 [TBL] [Abstract][Full Text] [Related]
20. CCL22-producing CD8α- myeloid dendritic cells mediate regulatory T cell recruitment in response to G-CSF treatment. Layseca-Espinosa E; Korniotis S; Montandon R; Gras C; Bouillié M; Gonzalez-Amaro R; Dy M; Zavala F J Immunol; 2013 Sep; 191(5):2266-72. PubMed ID: 23878314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]